ArticleHuman vaccines & immunotherapeutics2016

Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis.

Roberto Gasparini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.